BioMed Research International / 2021 / Article / Tab 2

Research Article

DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer

Table 2

Associate of DUOX2 mRNA expression with clinicopathological characteristics.

VariableGroupNumber of cases (%)DUOX2 expression value
HighLow

GenderMale62 (72.1)29330.336
Female24 (27.9)1410
Age (years)Age (years)>6537 (43.0)17200.514
6549 (57.0)2623
Tumor diameter (cm)>267 (77.9)38290.019
219 (22.1)514
Tumor locationHead57 (66.3)27300.494
Body/tail29 (33.7)1613
TNM stageI-IIA43 (50)15280.005
IIB-IV43 (50)2815
T stageT120 (23.3)6140.041
T2-366 (76.7)3729
N stageAbsent46 (53.5)15310.001
Present40 (46.5)2812
M stageM085 (98.8)43421
M11 (1.2)01
Histological stageI-II/II31 (36)15160.822
II-III/III55 (64)2827
Serum CA-199 (kU/L)Serum CA-199 (kU/L)3959 (72)31280.275
<3923 (28)914
Serum CEA (μg/L)4.729 (35.4)13160.596
<4.753 (64.6)2726
Perineural invasionAbsent14 (16.5)4100.088
Present71 (83.5)3833

, , and .